Skip to main content

Published locations for PROTECT trial: No DFS benefit with adjuvant pazopanib for high-risk RCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. PROTECT trial: No DFS benefit with adjuvant pazopanib for high-risk RCC

User login

  • Reset your password
  • /content/protect-trial-no-dfs-benefit-adjuvant-pazopanib-high-risk-rcc
  • /oncologypractice/article/147151/renal-cell-carcinoma/protect-trial-no-dfs-benefit-adjuvant-pazopanib
  • /hematology-oncology/article/147151/renal-cell-carcinoma/protect-trial-no-dfs-benefit-adjuvant